SOPHiA GENETICS CTO granted options and RSUs
SOPHiA GENETICS SA Chief Technology Officer Abhimanyu Verma received new equity awards as part of his compensation.
Rhea-AI Filing Summary
SOPHiA GENETICS SA Chief Technology Officer Abhimanyu Verma received new equity awards as part of his compensation. He was granted options to buy 119,760 ordinary shares at an exercise price of $5.04 per share, vesting 25% on April 2, 2027 and monthly through April 2, 2030. He also received 82,136 restricted stock units, with 25% vesting on April 2, 2027 and the remaining 75% in equal quarterly installments through April 2, 2030. These are awards from the company, not open-market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 201,896 shares
Grant/Award
2 txns
Insider
Verma Abhimanyu
Role
Chief Technology Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Share Option (Right to Buy) | 119,760 | $0.00 | $0.00 |
| Grant/Award | Ordinary Shares | 82,136 | $0.00 | $0.00 |
Holdings After Transaction:
Share Option (Right to Buy) — 119,760 contracts (Direct);
Ordinary Shares — 82,136 shares (Direct)
Footnotes (2)
- F1. Represents a restricted stock unit ("RSU") grant made under the Issuer's 2021 Equity Incentive Plan. Each RSU represents a contingent right to receive one ordinary share of the Issuer, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date. 25% of the RSUs will vest on April 2, 2027, and the remaining 75% will vest in equal quarterly installments through April 2, 2030.
- F2. The share option vests and becomes exercisable as to 25% of the ordinary shares on April 2, 2027, and then in equal monthly installments through April 2, 2030.
Key Figures
Option grant size: 119,760 shares
Option exercise price: $5.04 per share
RSU grant size: 82,136 units
+3 more
6 metrics
Option grant size
119,760 shares
Share options granted on 2026-04-02
Option exercise price
$5.04 per share
Conversion or exercise price for granted options
RSU grant size
82,136 units
Restricted stock units representing ordinary shares
Option expiration
April 2, 2036
Expiration date of the option grant
Initial vesting date
April 2, 2027
25% of both RSUs and options vest on this date
RSU vesting end
April 2, 2030
Remaining 75% of RSUs vest quarterly through this date
Key Terms
restricted stock unit ("RSU"), 2021 Equity Incentive Plan, share option, vesting, +1 more
5 terms
restricted stock unit ("RSU") financial
"Represents a restricted stock unit ("RSU") grant made under the Issuer's 2021 Equity Incentive Plan."
2021 Equity Incentive Plan financial
"RSU grant made under the Issuer's 2021 Equity Incentive Plan."
vesting financial
"subject to the Reporting Person's continued service with the Issuer through each applicable vesting date."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"conversion_or_exercise_price": "5.0400""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did SOPH Chief Technology Officer Abhimanyu Verma report?
Abhimanyu Verma reported receiving equity awards, not open-market trades. He was granted options on 119,760 ordinary shares at $5.04 per share and 82,136 restricted stock units, both subject to multi-year vesting schedules tied to his continued service with SOPHiA GENETICS SA.
How many SOPH options were granted to the CTO and at what exercise price?
The CTO received options covering 119,760 ordinary shares with a $5.04 exercise price. These options vest 25% on April 2, 2027, then in equal monthly installments through April 2, 2030, aligning his long-term incentives with SOPHiA GENETICS SA’s future performance and retention.
What are the terms of the 82,136 SOPH restricted stock units granted?
The filing shows a grant of 82,136 restricted stock units to the CTO. Each unit represents a right to receive one ordinary share, with 25% vesting on April 2, 2027 and the remaining 75% vesting in equal quarterly installments through April 2, 2030, contingent on continued service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
